Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-06 | Amended | $3,481,740 | $670,001 | Equity Only | 06b | SEC link |
| 2024-08-14 | Amended | $2,811,739 | $334,989 | Equity Only | 06b | SEC link |
| 2023-12-04 | New | $2,476,750 | $2,476,750 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jon Fernandez | Executive |
| Mike Freeman | Director |
| Jim Kasic | Director |
| Melissa Krebs | Director, Executive |
| Diana Verrilli | Director |